MOAI conducted a study with support from Johnson & Johnson MedTech Portugal, highlight the economic and clinical dimensions of the obesity burden: direct treatment of the disease costs 1.9 billion euros annually, to which must be added another 1.5 billion in expenses related to associated conditions, such as diabetes, hypertension, and various types of cancer.
Health and economic gains from bariatric surgery in Portugal: an in-depth analysis using a Markov model
MOAI developed a Markov model to assess the long-term cost-effectiveness of bariatric surgery compared with conventional treatment in the Portuguese healthcare setting. Published in Health Economics Review, the study showed that bariatric surgery is cost-effective within 10 years, becomes cost-saving after 20 years, and provides an additional 7 quality-adjusted life years (QALYs) while reducing lifetime healthcare costs by €4,534 per patient.
